KeyBanc still expects Veeva to retain majority of CRM customers

KeyBanc notes that Salesforce (CRM) announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement. The company will leverage Salesforce’s platform, including Agentforce and Data Cloud, to deploy personalized AI agents, supporting operations from medical to commercial and patient support functions. The loss of Takeda to Salesforce follows news late last year of a different Top 20 pharma company choosing to develop a customized solution with Salesforce instead of Vault CRM, the firm notes. Despite this, KeyBanc points out Veeva (VEEV) expects to retain the vast majority of its Veeva CRM customers, and for most of the top 20 pharma companies to decide on whether to migrate to Vault CRM in 2025 & 2026.